CardioVascular, CardioRenal and Cardiometabolic medicine is increasingly evidence-based. Every year brings a series of landmark, game changing trials. These are presented at major meetings "Late Breaking Clinical Trials sessions", which last only 10 minutes, followed by 5 mins discussion. Sometimes only the main results are published simultaneously or short after the event. Limited discussion among commentators may occur on social media.
CVCT is the only global meeting where hours are spent discussing individual trials, among the most authoritative stakeholders.
Public Calendar: November 27 - December 3, 2022This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Event Date: 12/03/2022
Location: Washington, DCSubject: Global CardioVascular Clinical Trialists Forum
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, academia, media, and other registered attendees
1 - 3 December 2022
CVCT is the only global meeting where hours are spent discussing individual trials, among the most authoritative stakeholders.
* CVCT is a unique think tank forum aiming at discussing the critical latest CardioVascular, CardioRenal and Cardiometabolic trials, individually and in context
* Discussion includes understanding trial rationale, design issues, trial conduct and operational issues, statistical methodology and interpretation, clinical meaning, approvability by major regulatory agencies, valuation by payers, implementation into practice guidelines, in real life by physicians.
* CVCT is unique in that it assembles the key global experts from multiple backgrounds.
* Academy trialists and Primary Investigators of major trials
* Pharma and Device Industry R&D and CROs.
* Regulatory agencies (FDA,EMA, MHRA, etc...)
* Major journal editors(NEJM, The Lancet, JAMA, Circ, JACC, EHJ…)
* Major research organisations (NHLBI, EC, Inserm..)
https://www.globalcvctforum.com/
Does anyone have any knowledge on on the above cvct forum. It appears in the fda calendar. Participants are restricted on social media so news may be limited. It appears that anyone in the cardiovascular clinical trial space would be involved, particularly when waiting dealing with the fda…
I would imagine this would play an important role in any decision made by the fda. Hopefully means a decision soon…
Can anyone with some knowledge in this space shed some light on this?
Add to My Watchlist
What is My Watchlist?
